Potential clinically significant drug‐drug interactions of hydroxychloroquine used in the treatment of COVID‐19

Abstract

Using HCQ has clinical debate whether it should or should not continue in COVID-19 patients, however, potential clinically significant DDIs identified in this study may optimise safety or efficacy of HCQ in considerable proportion of patients.